Evidence map›Paper›PMID 40160095›Full record

ArticleFuture science OA2025

Oxidative markers and SOD variant: predictors of autism severity and susceptibility.

Abdullah Abubaker Shareef, Azad Hasan Kheder, Niaz Albarzinji, Karim Jalal Karim, Shukur Wasman Smail, Abuabkr Abdalla Mahmood, Kawa Amin

Abstract read
In one paragraph

Article in Future science OA, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Abdullah Abubaker ShareefDepartment of Biology, College of Science, Salahaddin University-Erbil, Erbil, Iraq.
Azad Hasan KhederPhysiotherapy Department Erbil Health and Medical Technical College, Erbil Polytechnic University, Erbil, Iraq.
Niaz AlbarzinjiCollege of Medicine, Hawler Medical University, Erbil, Iraq.
Karim Jalal KarimDepartment of Medical Laboratory Science, Faculty of Science and Health, Koya University, Erbil, Iraq.
Shukur Wasman SmailDepartment of Biology, College of Science, Salahaddin University-Erbil, Erbil, Iraq.ORCID 0000-0001-8188-2540
Abuabkr Abdalla MahmoodDepartment of Biosciences and Chemistry, Sheffield Hallam University, Sheffield, UK.
Kawa AminCollege of Medicine, University of Sulaimani, Sulaymaniyah, Iraq.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study examines the relationship between oxidative stress, anti-oxidative markers, and the Ala16Val SOD2 polymorphism in children with autism spectrum disorder (ASD) to better understand ASD severity and susceptibility. MATERIAL AND

methodsThe study included 80 children (40 with ASD and 40 controls) from Erbil City, Iraq.

resultsSerum antioxidant markers, such as superoxide dismutase (SOD) and glutathione peroxidase (GPX), were significantly lower in ASD patients compared to controls (P = 0.036 and P < 0.001, respectively), while markers of oxidative damage, including malondialdehyde (MDA), nitric oxide (NO), and cytochrome C, were significantly elevated (P < 0.001). Regression analysis revealed reduced SOD and GPX activities were strongly associated with increased autism severity, as measured by the childhood autism rating scale (CARS), while elevated NO and cytochrome C levels also correlated positively with higher CARS scores. Although the Ala16Val SOD polymorphism was not significantly associated with ASD risk, logistic regression showed no connection between SOD genotypes and serum SOD levels.

conclusionThese findings suggest oxidative stress and impaired antioxidant defense play critical roles in ASD severity.

Indexed as

antioxidant defenseAutism spectrum disorderCARS scoreoxidative stresspolymorphismseveritysuperoxide dismutase

Identifiers

PMID40160095
PMCPMC11959902

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.